Thompson Siegel & Walmsley’s Atrion Corp ATRI Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ATRI Stock Details ATRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3	Closed	-$2K	–	968
2016 Q4	$2K	Buy	+3	New	+$1.39K	﹤0.01%	794

Other funds holding ATRI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Thompson Siegel & Walmsley's ATRI Position: Q1 2017 in Review

Thompson Siegel & Walmsley sold out of Atrion Corp (ATRI) in Q1 2017, closing a stake of 3 shares — an estimated $2K sold.

Thompson Siegel & Walmsley first reported a position in ATRI in Q4 2016 and held it in 1 quarter. The position peaked at $2K in Q4 2016. 118 funds tracked by Wall St. Rank hold ATRI as of Q1 2017.

Thompson Siegel & Walmsley reported no remaining Atrion Corp position as of Q1 2017 after selling out during the quarter.
Thompson Siegel & Walmsley sold 3 Atrion Corp shares in Q1 2017, an estimated $2K.
Thompson Siegel & Walmsley first reported a position in Atrion Corp in Q4 2016 and held it in 1 quarter.
Thompson Siegel & Walmsley's Atrion Corp position peaked at $2K in Q4 2016.
118 funds tracked by Wall St. Rank held Atrion Corp as of Q1 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2017, filed 15 May 2017.